Therapeutic results of intra-arterial thrombolysis after full-dose intravenous tissue plasminogen activator administration

American Journal of Neuroradiology

Volumn 31, Issue 8, 2010, Pages 1536-1540

  Yoo, Do Sung ^a   Won, Y D ^a   Huh, P W ^a   Shin, H E ^a   Kim, K T ^a   Kang, S G ^a   Lee, S B ^a   Cho, K S ^a  

^a Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOLYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RECANALIZATION; REPEATED DRUG DOSE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; YOUNG ADULT;

EID: 77956631119     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2084     Document Type: Article

References (37)

1. Abe O, Aoki S, Shirouzu I, et al. MR imaging of ischemic penumbra. Eur J Radiol 2003;46:67-78
2. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. New Engl J Med 1995;333:1581-87
3. Hacke W, Kaste M, Fieschi C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25
4. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups - the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711. Epub 2007 Apr 12
5. Bourekas EC, Slivka AP, Shah R, et al. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery 2004;54:39-46
6. Suarez JI, Zaidat OO, Sunshine JL, et al. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002;50:251-60
7. Madden K. Optimal timing of thrombolytic therapy in acute ischaemic stroke. CNS Drugs 2002;16:213-18
8. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra- arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603-10
9. Macleod MR, Davis SM, Mitchell PJ, et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005;20:12-17. Epub 2005 May 30
10. Mazighi M, Serfaty JM, Labreuche J, et al, for the RECANALISE investigators. Comparison of intravenous alteplase with a combined intravenousendovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-09. Epub 2009 Jul 31
11. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-605
12. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11. Epub 2004 Mar 11
13. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35. Epub 2007 May 24
14. Grandin CB. Assessment of brain perfusion with MRI: methodology and application to acute stroke. Neuroradiology 2003;45:755-66
15. Albers GW, Thijs VN, Wechsler L, et al, for the DEFUSE investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-17
16. Singer OC, Du Mesnil De Rochemont R, Foerch C, et al. Early functional recovery and the fate of the diffusion/perfusion mismatch in patients with proximal middle cerebral artery occlusion. Cerebrovasc Dis 2004;17:13-20. Epub 2003 Oct 3
17. Masdeu JC, Irimia P, Asenbaum S, et al. EFNS guideline on neuroimaging in acute stroke: report of an EFNS task force. Eur J Neurol 2006;13:1271-83
18. Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318-28
19. Schellinger PD, Thomalla G, Fiehler J, et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007;38:2640-45
20. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485-90
21. Davis SM, Donnan GA, Parsons MW, et al, for the EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309. Epub 2008 Feb 28
22. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology 2002;223:361-70
23. Yoon W, Seo JJ, Kim JK, et al. Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke 2004;35:876-81
24. Kim KT, Park JK, Kang SG, et al. Comparison of the effect of decompressive craniectomy on different neurosurgical diseases. Acta Neurochir (Wien) 2009;151:21-30
25. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981;12:723-25
26. Heiss WD, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998;18:1298-307
27. Furlan M, Marchal G, Viader F, et al. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol 1997;41:411-14
28. Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, et al, for the Kompetenznetz Schlaganfall Study Group. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109-14. Epub 2003 Dec 11
29. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73
30. Lee DH, Jo KD, Kim HG, et al. Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002;13:769-74
31. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
32. Paciaroni M, Agnelli G, Corea F, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome- results of a prospective multicenter study. Stroke 2008;39:2249-56
33. Mielke O, Wardlaw J, Liu M. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke. Cochrane Database Syst Rev 2004;18:CD000514
34. Abou-Chebl A, Bajzer CT, Krieger DW, et al. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke 2005;36:2286-88. Epub 2005 Sep 22
35. Rashdan I, Schechter E. Safety and efficacy of abciximab use in conjunction with intracoronary urokinase in patients requiring angioplasty. Catheter Cardiovasc Interv 2000;49:113-16
36. Qureshi AI, Suri MF, Khan J, et al. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery 2000;46:1316-24
37. Ringleb PA, Schellinger PD, Schranz C, et al. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke 2002;33:1437-41